Skip to main content

Advertisement

Table 2 Pairwise treatment comparisons from network meta-analyses for the outcomes response (main outcome measure, above the diagonal) and remission of symptoms (below the diagonal)

From: Comparative effectiveness of psychological treatments for depressive disorders in primary care: network meta-analysis

Ftf CBT 1.26 1.61 1.05 1.09 0.96 No data 1.07 1.17 0.04 1.08 0.94 0.89 1.26 0.84 1.80
0.80–2.00 0.98–2.55 0.32–3.65 0.77–1.55 0.69–1.34 0.71–1.60 0.74–1.87 0.000.25 0.45–2.71 0.54–1.67 0.55–1.46 0.78–2.08 0.32–2.14 1.332.37
1.19 Ftf PST 1.28 0.84 0.87 0.76 No data 0.85 0.94 0.03 0.86 0.75 0.71 1.00 0.67 1.43
0.72–1.88 0.79–1.97 0.26–2.91 0.55–1.33 0.48–1.18 0.53–1.41 0.55–1.53 0.000.19 0.40–1.93 0.44–1.27 0.49–1.03 0.61–1.72 0.26–1.82 1.00–2.06
1.38 1.16 Ftf IPT 0.65 0.68 0.60 No data 0.66 0.73 0.02 0.67 0.59 0.55 0.78 0.52 1.11
0.79–2.29 0.71–1.91 0.19–2.21 0.41–1.10 0.370.95 0.42–1.13 0.42–1.25 0.000.15 0.31–1.58 0.380.87 0.380.78 0.49–1.30 0.19–1.39 0.77–1.64
0.80 0.67 0.58 Ftf PDT 1.04 0.91 No data 1.02 1.12 0.03 0.00–0.31 1.03 0.90 0.85 1.20 0.80 1.71
0.22–2.95 0.18–2.38 0.15–2.08 0.32–3.35 0.27–3.11 0.31–3.30 0.31–3.67 0.26–4.50 0.27–3.02 0.28–2.58 0.33–4.32 0.18–3.42 0.53–5.78
0.88 0.74 0.64 1.09 Ftf Other 0.88 No data 0.98 1.08 0.03 0.99 0.87 0.82 1.15 0.77 1.65
0.58–1.29 0.45–1.20 0.37–1.13 0.30–4.11 0.60–1.30 0.65–1.46 0.69–1.67 0.000.22 0.45–2.28 0.49–1.53 0.52–1.32 0.71–1.94 0.33–1.86 1.262.14
0.99 0.83 0.72 1.24 1.13 Rtl CBT No data 1.12 1.22 0.04 1.13 0.98 0.93 1.31 0.88 1.87
0.65–1.51 0.51–1.41 0.41–1.28 0.33–4.61 0.68–1.83 0.72–1.74 0.77–2.02 0.000.25 0.49–2.72 0.54–1.79 0.57–1.53 0.77–2.22 0.34–2.32 1.412.56
1.17 0.98 0.85 1.46 1.33 1.18 Rtl PST No data No data No data No data No data No data No data No data No data
0.27–4.83 0.24–4.00 0.18–3.71 0.21–9.89 0.30–5.69 0.27–5.22
0.86 0.72 0.62 1.07 0.98 0.86 0.73 Gsh CBT 1.10 0.03 1.01 0.88 0.83 1.17 0.79 1.68
0.49–1.42 0.41–1.24 0.35–1.16 0.29–4.05 0.55–1.75 0.49–1.56 0.17–3.21 0.69–1.79 0.000.22 0.42–2.55 0.48–1.57 0.49–1.38 0.70–2.00 0.31–2.03 1.192.30
1.08 0.91 0.78 1.34 1.23 1.09 0.92 1.26 Nmc CBT 0.03 0.92 0.80 0.76 1.07 0.72 1.53
0.60–2.00 0.50–1.72 0.41–1.58 0.34–5.37 0.66–2.31 0.58–2.19 0.20–4.13 0.65–2.45 0.000.22 0.39–2.21 0.42–1.52 0.45–1.29 0.59–1.93 0.27–2.03 1.052.17
0.08 0.06 0.05 0.09 0.09 0.08 0.06 0.09 0.03 Ftf CBT + SSRI 30.6 26.7 25.12 35.6 23.8 50.8
0.010.40 0.010.34 0.010.30 0.010.85 0.010.46 0.010.42 0.010.55 0.010.48 0.000.22 4.59323 4.07289 4.00252 4.93397 2.61303 7.47587
0.99 0.83 0.72 1.23 1.13 1.00 0.85 1.15 0.92 13.2 Ftf PST + SSRI 0.87 0.82 1.16 0.78 1.66
0.35–2.27 0.35–1.91 0.26–1.75 0.27–5.57 0.41–2.67 0.36–2.33 0.17–4.06 0.44–3.02 0.39–2.21 2.16106 0.35–2.06 0.36–1.85 0.47–3.06 0.22–2.59 0.72–3.56
0.99 0.83 0.72 1.24 1.13 1.00 0.85 1.16 0.80 13.2 1.00 Ftf IPT + SSRI 0.94 1.33 0.89 1.90
0.52–1.91 0.47–1.57 0.43–1.24 0.31–5.05 0.59–2.18 0.51–2.02 0.19–4.06 0.56–2.28 0.42–1.52 2.1996.9 0.38–2.83 0.63–1.42 0.75–2.45 0.33–2.63 1.163.19
1.01 0.85 0.73 1.26 1.15 1.01 0.86 1.17 0.76 13.4 1.02 1.01 SSRI 1.41 0.95 2.02
0.61–1.64 0.57–1.23 0.48–1.12 0.37–4.43 0.70–1.91 0.60–1.74 0.20–3.72 0.68–2.03 0.45–1.29 2.5791.3 0.47–2.43 0.57–1.69 0.84–2.50 0.37–2.54 1.373.00
1.03 0.86 0.75 1.28 1.17 1.04 0.88 1.20 1.07 13.7 1.04 1.04 1.02 TCA 0.67 1.43
0.59–1.75 0.50–1.42 0.45–1.25 0.35–4.75 0.66–1.97 0.59–1.83 0.21–4.35 0.66–2.26 0.59–1.93 2.52100 0.41–2.88 0.53–1.99 0.61–1.76 0.24–1.85 0.91–2.18
0.60 0.50 0.43 0.75 0.68 0.60 0.51 0.70 0.72 7.96 0.61 0.60 0.59 0.58 Individ. Antid. 2.13
0.23–1.52 0.20–1.33 0.15–1.23 0.15–3.72 0.28–1.63 0.22–1.66 0.10–2.54 0.25–2.04 0.27–2.03 1.1874.0 0.17–2.13 0.21–1.71 0.22–1.64 0.22–1.59 0.86–5.33
1.53 1.28 1.11 1.90 1.74 1.54 1.31 1.78 1.53 20.3 1.54 1.54 1.51 1.48 2.55 UC/placebo
1.092.13 0.89–1.85 0.72–1.72 0.55–6.69 1.212.53 1.072.29 0.31–5.44 1.152.65 1.052.17 3.8161 0.69–3.96 0.86–2.76 1.052.23 0.92–2.39 1.00–6.67
  1. With regard to response, odds ratios higher than 1 favor the row-defining treatment, and odds ratios lower than 1 favor the column-defining treatment. With regard to remission, odds ratios higher than 1 favor the column-defining treatment, and odds ratios lower than 1 favor the row-defining treatment. Reciprocals should be used to obtain odds ratios in the opposite direction. Bold-faced figures indicate a difference between treatments with 95 % credible intervals of estimates excluding 1
  2. Abbreviations: CBT = cognitive behavioral therapy; Ftf = face-to-face; Gsh = guided self-help; IPT = interpersonal therapy; Nmc = no/minimal contact; PDT = psychodynamic therapy; PST = problem solving therapy; Rtl = remote therapist-lead; SSRI = selective serotonin reuptake inhibitors; TCA = tricyclic and tetracyclic antidepressants; UC = usual care
  3. The results are odds ratios with 95 % credible intervals when comparing the column-defined treatments with the row-defined treatments